Earnings summaries and quarterly performance for ESSA Pharma.
Executive leadership at ESSA Pharma.
Board of directors at ESSA Pharma.
Research analysts covering ESSA Pharma.
Recent press releases and 8-K filings for EPIX.
ESSA Pharma Security Holders Approve Business Combination and Related Resolutions
EPIX
M&A
Executive Compensation
Proxy Vote Outcomes
- Security holders of ESSA Pharma Inc. approved a special resolution for a plan of arrangement involving the company, Zenotherapeutics Incorporated, Zeno Acquisition Incorporated, and Zoma Royalty Corporation, pursuant to a Business Combination Agreement dated July 13, 2025, as amended on September 23, 2025.
- Shareholders also approved a non-binding advisory resolution regarding compensation for the company's named executive officers that is based on or otherwise relates to the arrangement.
- Additionally, a liquidation resolution and a liquidator resolution (appointing PricewaterhouseCoopers LLP or an alternative) were approved, which were contingent on the arrangement resolution not being approved or otherwise terminated.
Oct 3, 2025, 9:00 PM
Quarterly earnings call transcripts for ESSA Pharma.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more